Morepen Laboratories (NSE:MOREPENLAB) Accounts Payable: ₹3,172 Mil (As of Mar. 2026)


NSE:MOREPENLAB Morepen Laboratories Ltd NSE:MOREPENLAB
71 GF Score
Price ₹59.79
GF Value ₹49.87
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Morepen Laboratories Accounts Payable?

Morepen Laboratories NSE:MOREPENLAB +6.02% 71 Accounts Payable is ₹3,172 Mil as of Mar. 2026. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 71/100 and a GF Value™ of ₹49.87 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Morepen Laboratories's Accounts Payable for the quarter that ended in Mar. 2026 was ₹3,172 Mil.

Morepen Laboratories's quarterly Accounts Payable declined from Sep. 2025 (₹2,427 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹3,172 Mil).

Morepen Laboratories's annual Accounts Payable increased from Mar. 2024 (₹2,950 Mil) to Mar. 2025 (₹3,633 Mil) but then declined from Mar. 2025 (₹3,633 Mil) to Mar. 2026 (₹3,172 Mil).

Morepen Laboratories Accounts Payable Related Terms

Morepen Laboratories Accounts Payable Historical Data

* Premium members only.

The historical data trend for Morepen Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morepen Laboratories Accounts Payable Chart

Morepen Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,581.16 2,268.79 2,950.28 3,633.03 3,172.38

Morepen Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,633.03 0.00 2,427.39 0.00 3,172.38
NSE:MOREPENLAB
71GF Score
Morepen Laboratories Ltd NSE:MOREPENLAB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morepen Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹3,172 Mil mean?
Morepen Laboratories (NSE:MOREPENLAB) has a Accounts Payable of ₹3,172 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Morepen Laboratories and its competitors.
Is Morepen Laboratories' Accounts Payable too high?
Morepen Laboratories' current Accounts Payable is ₹3,172 Mil. Overall, Morepen Laboratories has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Accounts Payable compare to ZTS and UTHR?
Morepen Laboratories' Accounts Payable of ₹3,172 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Morepen Laboratories and its competitors. Morepen Laboratories's current Accounts Payable is ₹3,172 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹49.87, compared to a current price of ₹59.79 — trading 19.9% above its estimated fair value. The current Accounts Payable is ₹3,172 Mil. Morepen Laboratories' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Accounts Payable is ₹3,172 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued. The current stock price of ₹59.79 is trading 19.9% above its estimated GF Value™ of ₹49.87. GuruFocus considers Morepen Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:MOREPENLAB:

  • Accounts Payable: ₹3,172 Mil
  • GF Value™: ₹49.87 vs. price of ₹59.79 (19.9% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Morepen Laboratories Business Description

Other Exchanges 500288:India
Address Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
71GF Score

Get the complete analysis for NSE:MOREPENLAB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹59.79
Price
₹49.87
GF Value